Business News: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

25Mar - by Editor - 0 - In STL.News

WALTHAM, MA (STL.News) – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, today announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash.

Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies. 

Continue reading Business News: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing at STL.News.

Source link